Pharmaceutical Regulatory Affairs: Open Access

Kirkpatrick CJ

Publications

• Research Article
  Non-Equivalence of Antibiotic Generic Drugs and Risk for Intensive Care Patients
  Author(s): Kirkpatrick CJ, Ramzan Rangoonwala, Mykhaylo Reshetnykov, Mike Barbeck and Shahram GhanaatiKirkpatrick CJ, Ramzan Rangoonwala, Mykhaylo Reshetnykov, Mike Barbeck and Shahram Ghanaati
  
  Background: The underlying axiom in applying generic drugs is the equivalence of their active ingredient with the (usually more expensive) innovator product, an all-embracing statement with the insidious result that physicians assume that the generic products have been subjected to the same rigorous testing regimens as the brand-name products. The present paper presents novel experimental data on an investigator-blinded comparison between the innovator imipenem antibiotic.. Read More»
  DOI: 10.4172/2167-7689.1000109

  Abstract PDF